^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in sterile water for injection.

^e Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^f Concentration unspecified.

^g Infused over one hour simultaneously with methotrexate.

^h Tested with 0.1% albumin human added.

ⁱ Lyophilized formulation tested.

^j Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^k Run at 21 mL/hr.

^l Given over 30 minutes by syringe pump.

^m Run at 94 mL/hr.

ⁿ Run at 10 mL/hr.

^o Given over one hour by syringe pump.

^p Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

^q Tested with albumin human 0.1%.

^r Test performed using the formulation WITHOUT edetate disodium.

^s Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

^t Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^u Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^v Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^w If sterile water for injection is used as the diluent, manufacturers recommend a maximum volume per dose of 50 mL.

^x Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^y Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

^z Run at 100 mL/hr.

^aa Test performed using the formulation WITH edetate disodium.

^bb Tested as the premixed infusion solution.

^cc Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^dd Salt not specified.

^ee Presence or absence of edetate disodium not specified.

^ff Not specified whether concentration refers to single component or combined components.

^gg Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilstatin and relebactam.

^hh Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.